Literature DB >> 28408027

Is Atrial Fibrillation a Preventable Disease?

Xin Du1, Jianzeng Dong1, Changsheng Ma2.   

Abstract

Atrial fibrillation (AF) is an increasing burden worldwide. However, AF prevention has not been emphasized enough in clinical practice or guidelines. In this paper, the authors review the associations of modifiable lifestyle factors, including alcohol abuse, smoking, physical inactivity, and unhealthy psychological stress, with the risk for AF development. The authors also review the associations of cardiovascular risk factors that can be better managed, including obesity and overweight, high blood pressure, diabetes, dyslipidemia, obstructive sleep apnea, and other cardiovascular diseases, with the risk for AF. The conclusion is that a high proportion of AF can be prevented by combining strategies, focusing on the high-risk population for better risk factor management, and emphasizing healthy lifestyle choices in the whole population.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  diabetes mellitus; hypertension; lifestyle; obesity; prevention; risk factors

Mesh:

Year:  2017        PMID: 28408027     DOI: 10.1016/j.jacc.2017.02.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

1.  Etiology, Pathology, and Classification of Atrial Fibrillation.

Authors:  Srishti Nayak; Balaji Natarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-29

2.  Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.

Authors:  Matthew A Fischer; Thomas M Vondriska
Journal:  J Mol Cell Cardiol       Date:  2021-02-06       Impact factor: 5.000

3.  Relationship Between Psychosocial Stressors and Atrial Fibrillation in Women >45 Years of Age.

Authors:  Sarah K Westcott; Leila Y Beach; Fumika Matsushita; Christine M Albert; Neal Chatterjee; Jorge Wong; David R Williams; Manickavasagar Vinayagamoorthy; Julie E Buring; Michelle A Albert
Journal:  Am J Cardiol       Date:  2018-08-17       Impact factor: 2.778

4.  Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Authors:  Susanna C Larsson; Elias Allara; Amy M Mason; Karl Michaëlsson; Stephen Burgess
Journal:  Circ Genom Precis Med       Date:  2019-03

5.  Incidence of Atrial Fibrillation in Elite Athletes.

Authors:  Araceli Boraita; Alejandro Santos-Lozano; María E Heras; Florencia González-Amigo; Susana López-Ortiz; Julián P Villacastín; Alejandro Lucia
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

Review 6.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

7.  Histopathological substrate of the atrial myocardium in the progression of obstructive sleep apnoea-related atrial fibrillation.

Authors:  Ling Zhang; Kun Ye; Jiasuoer Xiaokereti; Mei Ma; Yankai Guo; Xianhui Zhou; Baopeng Tang
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

8.  Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times.

Authors:  Olívia Moraes Ruberti; Guilherme Defante Telles; Bruno Rodrigues
Journal:  Curr Cardiol Rev       Date:  2021

9.  Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women

Authors:  Humberto Rodríguez-Reyes; César I Laguna-Muñoz; Carlos F Gallegos-de Luna; Manuel O de-Los-Ríos-Ibarra; José L Salas-Pacheco; José L Leyva-Pons; Luz M Muñoz-Gutiérrez; Arturo Vargas-Hernandez; Karla M Rodríguez-Muñoz; Jaime Barragán-Luna; Marco A Alcocer-Gamba; Jorge Cortez-Lawrenz; Julio Farjat-Ruiz
Journal:  Arch Cardiol Mex       Date:  2022-07-01

Review 10.  Treatment of atrial fibrillation: a comprehensive review and practice guide.

Authors:  Jianhua Li; Mei Gao; Minwei Zhang; Donglu Liu; Zhan Li; Juanjuan Du; Yinglong Hou
Journal:  Cardiovasc J Afr       Date:  2020-03-18       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.